Kennedy Capital Management, Inc. Sc Pharmaceuticals Inc. Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $3,306 - $4,907	-942 Reduced 0.43%	218,812 $951,000
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $15,775 - $20,741	-3,246 Reduced 1.46%	219,754 $1.1 Million
Q4 2023 Feb 14, 2024	SELL	$4.7 - $6.63 $16,938 - $23,894	-3,604 Reduced 1.59%	223,000 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $910,948 - $1.71 Million	226,604 New	226,604 $1.62 Million

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.